End-of-Day and Historical Options Data for US Stocks Learn more

Novo Nordisk A/S Class B (0QIU IL) stock market data APIs

kr309.0569 1.35(0.4%)
as of December 2, 2025
Try our APIs with free plan!

Novo Nordisk A/S Class B Financial Data Overview

Price chart is built with Anychart
ISIN: DK006249**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Prev. Close 309.0569
Open 310.4077
High 312.9669
Low 305.1826
52 wk Range 267.05-777.7544
Market Cap 1 306 405 M
P/E Ratio 20.9371
Shares Outstanding 3 396 M
Revenue 201 325 M
EPS 4.499
Dividends (Yield) 0.0225
Beta 0.2105

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Novo Nordisk A/S Class B data using free add-ons & libraries


Get Novo Nordisk A/S Class B Fundamental Data

Novo Nordisk A/S Class B Fundamental data includes:

  • Net Revenue: 201 325 M
  • EBITDA: 92 893 M
  • Earnings Per Share: 14
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Novo Nordisk A/S Class B Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-09-30
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Novo Nordisk A/S Class B End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.